Critical Quality Control Issues of Antibiotic Susceptibility Tests for Developing Countries
International Journal of Pathogen Research,
Antibiotic therapy has been the mainstay of treatment of bacterial infections and the initial successes of the earlier generations of antibiotics for treatment and prevention of bacterial infections spurred further efforts to discover newer antibiotics. Antibiotic Susceptibility Test (AST) is a standardized procedure usually carried out on cultivable bacterial pathogens to determine their sensitivity to specific antibiotics, and to guide physicians on the best antibiotic treatment regimens for specific infections. The quality assurance and control for antibiotic susceptibility tests should be prioritized in deliberate efforts to reduce the burden of antibiotic resistant bacterial infections in developing countries.
- Antibiotic therapy
- antibiotic susceptibility test
- bacterial infections
How to Cite
Murray AK. The Novel Coronavirus COVID-19 Outbreak: Global implications for antimicrobial resistance. Front Microbiol. 2020;11:1020.
Boutayeb A. The burden of communicable and non-communicable diseases in developing countries. Handbook of Disease Burdens and Quality of Life Measures. 2010: 531–546.
Doron S, Gorbach SL. Bacterial infections: Overview. International Encyclopedia of Public Health. 2008:273–282.
Mokomane M, Kasvosve I, De Melo E, Pernic JM, Goldfarb DM. The global problem of childhood diarrheal diseases: Emerging strategies in prevention and management. Therap adv in Infect Dis. 2018;5(1):29–43.
Ugboko HU, Nwinyi OC, Oranusi SU, Oyewale JO. Childhood diarrheal diseases in developing countries. Heliyon. 2020;6(4).
Glaziou P, Sismanidis C, Floyd K, Raviglione M. Global epidemiology of tuberculosis. Cold Spring Harbor Perspectives in Medicine. 2014;5(2):a017798.
MacNeil A, Glaziou P, Sismaniis C, Maloney S, Floyd K. Global epidemiology of tuberculsis and progress toward achieving global targets-2017. MMWR. 2019;68(11):263–266.
Adatara P, Afaya A, Mohammed Salia S, Afaya RA, Konlan KD, Agyabeng-Fandoh E, Agbinku E, Ayandayo EA Boahene IG. Risk factors associated with neonatal sepsis: A case study at a specialist hospital in Ghana. Sci World Jour; 2019.
Andoh LA, Ahmed S, Olsen JE, Obiri-Danso K, Newman MJ, Opintan JA, Barco L, Dalsgaard A. Prevalence and characterization of Salmonella among humans in Ghana. TropMed Health. 2017; 45:3.
Sia S, Lagrada M, Olorosa A, Limas M, Jamoralin JM, Macaranas PK, Espiritu HG, Gayeta J, Masim MA, Ablola FB, Carlos C. A fifteen-year report of serotype distribution and antimicrobial resistance of salmonella in the Philippines. Phil Jour of Pathol. 2020;5(1).
Aminov RI. A brief history of the antibiotic era: Lessons learned and challenges for the future. Front Microbioly. 2010;1:134.
Bediako-Bowan AAA, Owusu E, Labi AK. Antibiotic use in surgical units of selected hospitals in Ghana: A multi-centre point prevalence survey. BMC Pub Health. 2019;19:797.
Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: Causes and control strategies. Antimicrob Resist Infect Control. 2017;6:47
Saldanha N, Runwal K, Ghanekar C. High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India. BMC Infect Dis. 2019;19: 391
Asgedom SW, Teweldemedhin M, Gebreyesus H. Prevalence of multidrug-resistant tuberculosis and associated factors in Ethiopia: A systematic review. Jour Pathogens. 2018;7(10):49-21.
Jafari F, Hamidian M, Rezadehbashi M, Doyle M, Salmanzadeh-Ahrabi S, Derakhshan F, Reza Zali M. Prevalence and antimicrobial resistance of diarrheagenic Escherichia coli and Shigella species associated with acute diarrhea in Tehran, Iran. Cana Jour Infect Dis Med Microbiol. 2009;20(3):e56–e62.
Qu M, Lv B, Zhang X, Yan H, Huang Y, Qian H, Pang B, Jia L, Kan B, Wang Q. Prevalence and antibiotic resistance of bacterial pathogens isolated from childhood diarrhea in Beijing, China (2010-2014). Gut Pathogens. 2016;8:31.
Dadgostar P. Antimicrobial resistance: Implications and costs. Infection and Drug Resistance. 2019;12:3903–3910.
Karatuna O. Quality assurance in antimicrobial susceptibility testing. Available online; 2012.
Available:https://www.intechopen.com/books/latest-research-into-quality-control/quality-assurance-in-antimicrobial-susceptibility-testing. Accessed: 25th November, 2020.
Chanda W, Manyepa M, Chikwanda E, Daka V, Chileshe J, Tembo M. Evaluation of antibiotic susceptibility patterns of pathogens isolated from routine laboratory specimens at Ndola Teaching Hospital: A retrospective study. PLoS ONE. 2019; 14(12):e0226676.
Bayot ML, Bragg BN. Antimicrobial susceptibility testing. [Updated 2020 Aug 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.
Kassim A, Omuse G, Premji Z. Comparison of clinical laboratory standards institute and european committee on antimicrobial susceptibility testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: A cross-sectional study. Ann Clin Microbiol Antimicrob. 2016;15:21.
Syal K, Mo M, Yu H, Iriya R, Jing W, Guodong S, Wang S, Grys TE, Haydel SE, Tao N. Current and emerging techniques for antibiotic susceptibility tests. Theranostics. 20177(7):1795–1805.
Khan ZA, Siddiqui MF, Park S. Current and Emerging Methods of Antibiotic Susceptibility Testing. Diagnostics (Basel, Switzerland). 2019;9(2):49.
King A, Brown DFJ. Quality assurance of antimicrobial susceptibility testing by disk diffusion. Journal of antimicrobial Chemotherapy. 2001;48(S1):71-76.
Cantón R. Role of the microbiology laboratory in infectious disease surveillance, alert and response. Clinical microbiology and infection: The official publication of the European Society of Clin Microbiol Infect Dis. 2005;11(1):3–8.
Rankin ID. Quality assurance/quality control (QA/QC) In: Coyle M. B. (ed.) Manual of antimicrobial susce- ptibility testing. 1st ed, Washington, D.C. American Society for Microbiology. 2005:63-89.
Abstract View: 48 times
PDF Download: 14 times